Recall: D-1425-2014

Class II - Potentially Harmful

Class IIClassification

2014-06-06Initiated

TerminatedStatus

Hospira Inc.Firm

Product

Heparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL), 250 mL, Single-Dose Container, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-7793-62

Reason

Lack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of bag.

Distribution

Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.